Science Explorer Back to mapMap
Discussion
Topic · Complementary and alternative medicine

Andrographolide Research and Applications

Andrographolide Research and Applications is a research topic within Complementary and alternative medicine. Science Explorer counts 3.8k research works in it since 1960. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the medicinal properties of Andrographis paniculata, particularly its bioactive compound andrographolide, and its potential applications in anticancer, immunostimulatory, anti-inflammatory, antioxidant, hepatoprotective, and antiviral treatments.

  • Andrographis Paniculata
  • Andrographolide
  • Anticancer
  • Immunostimulatory
  • Anti-inflammatory
  • Antioxidant
  • Hepatoprotective
  • Antiviral
  • Pharmacological Activities
  • Bioactive Compounds
Research works
3.8k
fractional, since 1960
In the world top 10%
394
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+54%
the tick is no change
Largest producer
China
44% of the 10 largest, 2022-now
Andrographolide Research and Applications

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Andrographolide Research and Applications research?

By volume, China and India publish the most (568 and 361 works in 2022-now).

By volume, 2022-now

  1. 1 China 568 works
  2. 2 India 361 works
  3. 3 Indonesia 104 works
  4. 4 United States 55 works
  5. 5 Thailand 50 works
  6. 6 Nigeria 38 works
  7. 7 Iran 31 works
  8. 8 South Korea 26 works
  9. 9 Malaysia 26 works
  10. 10 Egypt 23 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 44.3%India: 28.1%Indonesia: 8.1%United States: 4.3%6 others listed: 15.2%44%largest
China568 · 44.3%India361 · 28.1%Indonesia104 · 8.1%United States55 · 4.3%6 others listed195 · 15.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Andrographolide Research and Applications research?

By volume in 2022-now, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Andrographolide Research and Applications research, followed by Beijing University of Chinese Medicine and Shanghai University of Traditional Chinese Medicine.

By volume, 2022-now

  1. 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
  2. 2 Beijing University of Chinese MedicineChina 19 works
  3. 3 Shanghai University of Traditional Chinese MedicineChina 17 works
  4. 4 Guangzhou University of Chinese MedicineChina 16 works
  5. 5 Chengdu University of Traditional Chinese MedicineChina 14 works
  6. 6 First Affiliated Hospital of Henan UniversityChina 13 works
  7. 7 Council of Scientific and Industrial ResearchIndia 12 works
  8. 8 Tianjin University of Traditional Chinese MedicineChina 9 works
  9. 9 Chinese Academy of SciencesChina 9 works
  10. 10 Saveetha UniversityIndia 8 works

Who are the leading researchers in Andrographolide Research and Applications?

The most-cited researchers publishing on Andrographolide Research and Applications include William J. Sandborn and Han Zhang.

  1. 1 William J. Sandborn United States 168k citations
  2. 2 Han Zhang China 161k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Andrographolide Research and Applications?

The most cited paper in Andrographolide Research and Applications is "Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes" (Axel Bouchon, Jes Dietrich, Marco Colonna, 2000), with 1,310 citations. Next come "Atherosclerosis: process, indicators, risk factors and new hopes." (825) and "Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome." (821).

Most cited papers
#PaperReleasedCitations
1 Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes Axel Bouchon, Jes Dietrich, Marco Colonna · The Journal of Immunology May 2000 1,310
2 Atherosclerosis: process, indicators, risk factors and new hopes. Mahmoud Rafieian‐Kopaei, Mahbubeh Setorki, Monir Doudi et al. · PubMed Open access Aug 2014 825
3 Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome. Yan Wang, Chu-Fan Xu, Yu-Jian Liu et al. · PubMed 2017 821
4 Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Lakshmi-Chandra Mishra, Betsy B Singh, Simon Dagenais · PubMed Aug 2000 779
5 Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Runfeng Li, Hou Yunlong, Huang Jicheng et al. · Pharmacological Research Open access 20 Mar 2020 686
All 100 most cited papers, with filters and sorting

Where is Andrographolide Research and Applications research done?

The largest centres of Andrographolide Research and Applications research in 2022-now are Beijing (China), Guangzhou (China), Shanghai (China) and Chennai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Bangkok and Chennai.

Largest cities, 2022-now

  1. 1 BeijingChina 79 works
  2. 2 GuangzhouChina 43 works
  3. 3 ShanghaiChina 35 works
  4. 4 ChennaiIndia 30 works
  5. 5 BangkokThailand 26 works
  6. 6 ChengduChina 24 works
  7. 7 HangzhouChina 22 works
  8. 8 New DelhiIndia 20 works
  9. 9 JinanChina 20 works
  10. 10 NanjingChina 18 works

Where it is the local speciality

  1. BangkokTH · 25.7 works7.4×
  2. ChennaiIN · 30.4 works4.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Andrographolide Research and Applications than the world average.

See Andrographolide Research and Applications on the map

Where is the best place to study Andrographolide Research and Applications?

Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, Beijing University of Chinese Medicine and Guangzhou University of Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 14.5143%fractional works in this field (log) →share of work in the world top 10% →Chengdu University o…Guangzhou University…Beijing University o…Chinese Academy of M…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Chengdu University of Traditional Chinese MedicineChina 78.919.3%42.9×14 +27.4%
2Beijing University of Chinese MedicineChina 74.215.6%60.1×19 +44.7%
3Guangzhou University of Chinese MedicineChina 73.215.8%52.6×16 +68.9%
4Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 67.412.3%14.3×20 +45.4%
5Shanghai University of Traditional Chinese MedicineChina 63.112.9%47.1×17 +82.7%
6Tianjin University of Traditional Chinese MedicineChina 55.018.1%49.0×10 +67.6%
7Saveetha UniversityIndia 20.07.6%6.6×8 +21.5%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Andrographolide Research and Applications, country by country

Is Andrographolide Research and Applications research growing?

Output in 2022-2025 was 54% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Andrographolide Research and Applications.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Andrographolide Research and Applications as a percentage of every work published that year, 0.0050% in 2024.

still counting0.0025%0.0050%0.0075%Andrographolide Research and Applications0.0065% in 202519801990200020102020

Fractional works of Andrographolide Research and Applications over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Andrographolide Research and Applications10.6% in 202520102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Andrographolide Research and Applications. Posts are plain text and can be reported.